|
Announcements
PALL CORPORATION SELECTS CLINIVATION GLOBAL®
XI.
Global leader in filtration, separation and purification technologies selects clinivation Global xi as
the foundation for managing their global market clearance operations.
Natick, MA, April 29, 2010
- clinivation, Inc. announced today that Pall Corporation has selected
the clinivation Global xi enterprise solution for Market Clearance
Management.
"Pall is a global leader in filtration, separation and purification technologies in the medical device industry. We are pleased
that they have selected the clinivation Global xi Market Clearance Platform as the foundation for managing their global market
clearance operations," said Richard Morroney, R.A.C., C.Q.A., clinivation's Vice President, Global Market
Clearance Solutions.
About the clinivation Global xi
Market Clearance Platform
The clinivation Global xi enterprise
solution for Market Clearance Management enables executives and their teams to
address the challenges of execution, effective governance, and lean business performance
in their global market clearance operations. By enabling excellence in global
market clearance operations to advance the revenue intrinsic to market clearance
success, clinivation Global xi liberates revenue that's trapped-in-process.
About Pall Corporation
Pall Corporation (NYSE:PLL) is a filtration, separation and purification leader providing Total Fluid Management solutions
to meet the critical needs of customers in biopharmaceutical, hospital and transfusion medicine, energy and alternative energy,
electronics, municipal and industrial water, aerospace, transportation and broad industrial markets. The Company’s engineered
solutions enable process and product innovation and minimize emissions and waste. Pall Corporation, with total revenues of $2.3
billion for fiscal 2009, is an S&P 500 company with more than 10,000 employees servicing customers worldwide. Pall has been
named a top "green company" by Newsweek magazine.
For more information about Pall, please visit www.pall.com
About
clinivation, Inc. Clinivation is the leading provider
of integrated solutions that enable global market clearance. Guided by our singular
vision - "Excellence in Market Clearance" - clinivation accelerates
the entire market clearance cycle to advance new worldwide revenue and achieve
new milestones of enterprise value. Used in over 1,000,000 product registrations
by more than 100 companies worldwide, clinivation's end-to-end technology and
services deliver on our vision by eliminating revenue traps from global market
clearance operations, increasing process velocity with on-demand regulatory intelligence,
automating clearance-driven business controls, simplifying content unification
into market clearance applications, aligning quality systems with global market
clearance priorities, streamlining clinical development with clearance-focused
trials, and enabling management with key performance indicators for continuous
improvement and effective governance. The world's leading medical device,
diagnostics, hospital supply, and dental supply companies select clinivation because
of our medtech industry focus and our unique, integrated solutions that seamlessly
adapt to existing business processes and enterprise infrastructure- without the
need to write custom code.
Our core brands include the clinivation Global xi
market clearance platform, clinivation WorldView on-demand regulatory intelligence,
and clinivation Clinical Suite and clinivation Registry Suite electronic data
capture and clinical data management software. Founded in 1999, the company
is headquartered in Natick, Massachusetts, with regional offices in North America
and Asia. Visit clinivation online at www.clinivation.com For
further information: For more information on clinivation's
integrated solutions that enable global market clearance, please click
here or call us at 508.655.6560. | 
